Opus Genetics is trading at $5.46 (+5.31%) as broader markets strengthen.

  • The S&P 500 is up 0.90%, while the Nasdaq is up 1.43%.
  • Falling oil prices, lower Treasury yields, and rising Bitcoin are supporting risk appetite on September 21, 2026.
  • No new company-specific announcement was identified; the September 9 clinical update remains prior context, not a same-day catalyst.